Evidence map›Paper›PMID 31432443›Full record

ArticleJournal of clinical immunology2019

A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.

Deniz Cagdas, Sevil Oskay Halaçlı, Çağman Tan, Bernice Lo, Pınar Gür Çetinkaya, Saliha Esenboğa, Betül Karaatmaca, Helen Matthews, Burcu Balcı-Hayta, Tuba Arıkoğlu and 13 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Infections in Disorders of Immune Regulation.Pathogens (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Early-Onset Diabetes in an Infant with a Novel Frameshift Mutation in LRBA.International journal of environmental research and public health · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 4 countries.

Deniz CagdasDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey. deniz.ayvaz@hacettepe.edu.tr.ORCID http://orcid.org/0000-0003-2213-4627
Sevil Oskay HalaçlıInstitute of Child Health, Immunology, Hacettepe University, Ankara, Turkey.
Çağman TanInstitute of Child Health, Immunology, Hacettepe University, Ankara, Turkey.
Bernice LoSidra Medical and Research Center, Al Rayyan, Qatar.
Pınar Gür ÇetinkayaDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey.
Saliha EsenboğaDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey.
Betül KaraatmacaDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey.
Helen MatthewsNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Burcu Balcı-HaytaDepartment of Medical Biology, Hacettepe University Medical School, Ankara, Turkey.
Tuba ArıkoğluDepartment of Pediatrics, Division of Allergy and Immunology, Mersin University Medical School, Mersin, Turkey.
Fatih EzgüDepartment of Pediatrics, Division of Pediatric Inborn Metabolic Disorders, Metabolism and Genetics, Gazi University Medical School, Ankara, Turkey.
Elifcan AladağDepartment of Internal Medicine, Division of Hematology, Hacettepe University Medical School, Ankara, Turkey.
İnci N Saltık-TemizelDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hacettepe University Medical School, Ankara, Turkey.
Hülya DemirDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hacettepe University Medical School, Ankara, Turkey.
Barış KuşkonmazDepartment of Pediatrics, Division of Pediatric Hematology, Hacettepe University Medical School, Ankara, Turkey.
Visal OkurDepartment of Pediatrics, Division of Pediatric Hematology, Hacettepe University Medical School, Ankara, Turkey.
Fatma GümrükDepartment of Pediatrics, Division of Pediatric Hematology, Hacettepe University Medical School, Ankara, Turkey.
Hakan GökerDepartment of Internal Medicine, Division of Hematology, Hacettepe University Medical School, Ankara, Turkey.
Duygu ÇetinkayaDepartment of Pediatrics, Division of Pediatric Hematology, Hacettepe University Medical School, Ankara, Turkey.
Kaan BoztuğCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Michael LenardoNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Özden SanalDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey.
İlhan TezcanDepartment of Pediatrics, Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey.
Hacettepe University · TRNational Institutes of Health · USAustrian Academy of Sciences · ATGazi University · TRMersin Üniversitesi · TRSidra Medical and Research Center · QA

Funding

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory DisordersZIAAI000769 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN · 2009 to 2024
$16.7M
Intramural NIH HHS ZIA AI000769
6 · The paper itself

Abstract

introductionAutosomal recessively inherited lipopolysaccharide-responsive beige-like anchor (LRBA) protein deficiency was shown to be responsible for different types of inborn errors of immunity, such as common variable immunodeficiency (CVID) and autoimmune lymphoproliferative syndrome (ALPS). The aim of this study was to compare patients with LRBA-related ALPS and LRBA-related CVID, to describe their clinical and laboratory phenotypes, and to prepare an algorithm for their diagnosis and management.

methodsFifteen LRBA-deficient patients were identified among 31 CVID and 14 possible ALPS patients with Western blotting (WB), primary immunodeficiency disease (PIDD) gene, next-generation panel screening (NGS), and whole exome sequencing (WES).

resultsThe median age on admission and age of diagnosis were 7 years (0.3-16.5) and 11 years (5-44), respectively. Splenomegaly was seen in 93.3% (14/15) of the patients on admission. Splenectomy was performed to 1/5. Recurrent upper respiratory tract infections (93.3% (14/15)), autoimmune cytopenia (80% (12/15)), chronic diarrhea (53.3% (8/15)), lower respiratory tract infections (53.3% (8/15)), lymphoma (26.6% (4/15)), Evans syndrome (26.6% (4/15)), and autoimmune thyroiditis (20% (3/15)) were common clinical findings and diseases. Lymphopenia (5/15), intermittant neutropenia (4/15), eosinophilia (4/15), and progressive hypogammaglobulinemia are recorded in given number of patients. Double negative T cells (TCRαβ

conclusionPatients with LRBA deficiency may initially be diagnosed as CVID or ALPS in the clinical practice. Progressive decrease in B cells as well as IgG in ALPS-like patients and addition of IBD symptoms in the follow-up should raise the suspicion for LRBA deficiency. Decreased switched memory B cells, decreased naive and recent thymic emigrant (RTE) Th cells, and markedly increased effector memory/effector memory RA

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdaptor Proteins, Signal TransducingAdolescentAdultAutoimmune Lymphoproliferative SyndromeBiomarkersChildChild, PreschoolCombined Modality TherapyCommon Variable ImmunodeficiencyCommunicable DiseasesExome SequencingFemaleGenetic LociHematopoietic Stem Cell TransplantationAdaptor Proteins, Signal TransducingBiomarkersLRBA protein, humanHsctLATAIELRBA deficiencyMalignancy

Identifiers

PMID31432443
PMCPMC11090043
OpenAlexW2969776998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.